Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$38.62 - $72.18 $4,286 - $8,011
-111 Reduced 1.87%
5,826 $364,000
Q3 2023

Nov 06, 2023

SELL
$45.39 - $59.0 $1,860 - $2,419
-41 Reduced 0.69%
5,937 $269,000
Q2 2023

Jul 13, 2023

SELL
$43.47 - $67.77 $12,519 - $19,517
-288 Reduced 4.6%
5,978 $335,000
Q1 2023

May 05, 2023

SELL
$41.0 - $56.12 $4,018 - $5,499
-98 Reduced 1.54%
6,266 $283,000
Q4 2022

Feb 06, 2023

SELL
$39.19 - $65.67 $38,758 - $64,947
-989 Reduced 13.45%
6,364 $258,000
Q3 2022

Nov 07, 2022

SELL
$61.1 - $83.78 $24,256 - $33,260
-397 Reduced 5.12%
7,353 $481,000
Q2 2022

Aug 01, 2022

BUY
$43.23 - $73.83 $335,032 - $572,182
7,750 New
7,750 $471,000
Q1 2022

May 02, 2022

SELL
$53.19 - $79.24 $352,064 - $524,489
-6,619 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$70.09 - $111.29 $95,883 - $152,244
1,368 Added 26.05%
6,619 $502,000
Q3 2021

Nov 15, 2021

BUY
$110.2 - $156.64 $19,615 - $27,881
178 Added 3.51%
5,251 $588,000
Q2 2021

Jul 23, 2021

SELL
$100.84 - $161.89 $250,688 - $402,458
-2,486 Reduced 32.89%
5,073 $751,000
Q1 2021

Apr 12, 2021

SELL
$110.72 - $210.04 $403,795 - $766,015
-3,647 Reduced 32.55%
7,559 $903,000
Q4 2020

Feb 05, 2021

BUY
$79.67 - $173.23 $892,782 - $1.94 Million
11,206 New
11,206 $1.72 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.1B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Phoenix Wealth Advisors Portfolio

Follow Phoenix Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Wealth Advisors with notifications on news.